secwatch.observer — SEC 8-K summary
======================================

Issuer:     RESMED INC (RMD)
CIK:        0000943819
Form:       8-K
Filed at:   2023-10-26T23:59:59+00:00
Accession:  0001193125-23-264072
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ResMed Q1 FY2024 revenue up 16% to $1.10B; non-GAAP EPS $1.64 (+9% YoY)
-----------------------------------------------------------------------

- Revenue $1,102.3M (+16% YoY); operating income $289.0M (+5%); non-GAAP operating profit +10%.
- Diluted EPS $1.49 (GAAP) and $1.64 (non-GAAP, +9% YoY); gross margin 54.4%, down 250 bps.
- Operating cash flow $286.3M; company expects to resume share repurchase program in upcoming quarter.
- Board declared quarterly dividend of $0.48/share, payable Dec 14, record Nov 9.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/943819/000119312523264072/0001193125-23-264072-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/943819/000119312523264072/d547248d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-264072

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer